3P Clinical significance of achieving no evidence of disease in HER2-positive metastatic breast cancer: A multicenter study by Turkish Oncology Group (TOG)
Achieving no evidence of disease (NED) in HER2-positive metastatic breast cancer (MBC) has been proposed as a surrogate for durable disease control. However, its clinical significance and predictive factors are not yet well established.
Authors
- Öznur Bal (ORCID: https://orcid.org/0000-0002-6901-2646)
- Tuğba Önder (ORCID: https://orcid.org/0000-0002-5997-0373)
- Serhat Sekmek (ORCID: https://orcid.org/0000-0003-4650-248X)
- H.C. Yildirim (ORCID: https://orcid.org/0000-0001-5013-8970)
- Savaş Gökçek (ORCID: https://orcid.org/0000-0001-5928-0447)
- Gözde Savaş
- Ü Y Arslan
- H.M. Türk
- Z. Sucuoglu Isleyen
- S. Ön
- F. Aslan
- N. Sever
- S. Yaslikaya
- H. Akbulut
- M. Sahbazlar
- B. Dursun
- G.S.Y. Keskin
- B. Cakar
- O. Acar
- M.E. Kalender
Institutions
- Ankara University (TR)
- Manisa Celal Bayar University (TR)
- Dokuz Eylül University (TR)
- Bezmiâlem Vakıf Üniversitesi (TR)
- Ege University (TR)
- Gülhane Askerî Tıp Akademisi (TR)
- Memorial Ankara Hospital (TR)
- Ankara Onkoloji Eğitim ve Araştırma Hastanesi (TR)
- Isparta University of Applied Sciences (TR)
- Başkent University Hospital (TR)
- Charisma University (TC)
- Cukurova University (TR)
- Hacettepe University (TR)
- Marmara University (TR)
- Gazi University (TR)
Publication Details
- Journal
- ESMO Open
- Published
- 2026-04-01
- DOI
- https://doi.org/10.1016/j.esmoop.2026.106106
- Primary Topic
- HER2/EGFR in Cancer Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00